MRI of carotid atherosclerosis to identify TIA and stroke patients who are at risk of a recurrence

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 5, 2013, Pages 1189-1194

  Kwee, Robert M ^a,b   Van Oostenbrugge, Robert J ^a,b   Mess, Werner H ^a,b   Prins, Martin H ^a,b   Van Der Geest, Rob J ^c   Ter Berg, Johannes W M ^d   Franke, Cees L ^d   Korten, Arthur G G C ^e   Meems, Bé J ^f   Van Engelshoven, Jos M A ^a,b   Wildberger, Joachim E ^a,b   Kooi, M Eline ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

^f VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

carotid atherosclerosis; MRI; plaque; stroke; TIA

Indexed keywords

AGED; ARTERY DIAMETER; ARTICLE; BLEEDING; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK;

AGED; CAROTID ARTERY DISEASES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NETHERLANDS; PROGNOSIS; RECURRENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84876491769     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23918     Document Type: Article

References (19)

1. Chaturvedi S, Bruno A, Feasby T, et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Carotid endarterectomy - an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005; 65: 794-801.
2. Kwee RM, van Oostenbrugge RJ, Hofstra L, et al. Identifying vulnerable carotid plaques by noninvasive imaging. Neurology 2008; 70: 2401-2409.
3. Redgrave JN, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006; 113: 2320-2328.
4. Spagnoli LG, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292: 1845-1852.
5. Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006; 19: 636-654.
6. Cappendijk VC, Cleutjens KB, Heeneman S, et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging 2004; 20: 105-110.
7. Moody AR, Murphy RE, Morgan PS, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003; 107: 3047-3052.
8. Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI - initial results. Stroke 2006; 37: 818-823.
9. Altaf N, Daniels L, Morgan PS, et al. Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg 2008; 47: 337-342.
10. Altaf N, MacSweeney ST, Gladman J, et al. Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke 2007; 38: 1633-1635.
11. Kwee RM, van Oostenbrugge RJ, Prins MH, et al. Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 2010; 41: 1389-1393.
12. Kwee RM, Teule GJ, van Oostenbrugge RJ, et al. Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging. Stroke 2009; 40: 3718-3824.
13. Kwee RM, van Engelshoven JM, Mess WH, et al. Reproducibility of fibrous cap status assessment of carotid artery plaques by contrast-enhanced MRI. Stroke 2009; 40: 3017-3021.
14. Cappendijk VC, Cleutjens KB, Heeneman S, et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging 2004; 20: 105-110.
15. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005; 25: 234-239.
16. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005; 112: 3437-3444.
17. Altaf N, Goode SD, Beech A, et al. Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. Radiology 2011; 258: 538-545.
18. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-116.
19. Underhill HR, Yarnykh VL, Hatsukami TS, et al. Carotid plaque morphology and composition: initial comparison between 1.5- and 3.0-T magnetic field strengths. Radiology 2008; 248: 550-560.